---
schema_version: "secwatch.filing_event.v1"
accession: "0001384101-21-000120"
form_type: "8-K"
ticker: "VCYT"
cik: "0001384101"
company_name: "VERACYTE, INC."
filed_at: "2021-07-13T23:59:59+00:00"
generated_at: "2026-06-30T05:40:47.588022+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Veracyte signs definitive agreement to acquire HalioDx for up to €113M in stock

## Summary
- Entered into Securities Purchase and Contribution Agreement on July 13, 2021.
- Consideration includes up to €113M in Veracyte common stock, with option to substitute cash.
- Closing subject to customary conditions, including French foreign investment authorization.
- Stock to be issued in private placement exempt from registration under Section 4(a)(2) and/or Regulation S.

## SEC filing metadata
- accession: 0001384101-21-000120
- form_type: 8-K
- ticker: VCYT
- cik: 0001384101
- company_name: VERACYTE, INC.
- filed_at: 2021-07-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1384101/000138410121000120/0001384101-21-000120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1384101/000138410121000120/vcyt-20210713.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001384101-21-000120
- JSON: https://secwatch.observer/filing/0001384101-21-000120.json
- Plain text: https://secwatch.observer/filing/0001384101-21-000120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.